ask="14.98"
ask_size="200"
average_daily_volume="1923510"
bid="14.80"
bid_size="100"
book_value="-0.25"
change="+0.82"
change_from_200_day_moving_average="3.15"
change_from_50_day_moving_average="2.01"
change_from_52_week_high="-0.07"
change_From_52_week_low="6.98"
change_in_percent="+5.92%"
close="14.68"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.81"
ebitda="-80.80M"
eps_estimate_current_year="-0.97"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.80"
ex_dividend_date="N/A"
float_shares="94778000"
high="14.75"
high_52_weeks="14.75"
last_trade_date="3/16/2017"
last_trade_price="14.68"
last_trade_size="58489"
last_trade_time="4:00pm"
low="13.68"
low_52_weeks="7.70"
market_capitalization="1.88B"
moving_average_200_day="11.53"
moving_average_50_day="12.67"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="13.84"
pe_ratio="N/A"
peg_ratio="-2.01"
percent_change_from_200_day_moving_average="+27.30%"
percent_change_from_50_day_moving_average="+15.86%"
percent_change_from_52_week_high="-0.47%"
percent_change_from_52_week_low="+90.65%"
previous_close="13.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="12.11"
revenue="146.69M"
shares_outstanding="128198000"
short_ratio="18.90"
stock_exchange="NMS"
symbol="HALO"
volume="3042767"
weeks_range_52="7.70 - 14.75"
